Senior Director, Therapeutic Area (Hepatology)

divh2Senior Director Therapeutic Area (Hepatology)- US- Remote/h2pICON is a global healthcare intelligence and clinical research organisation united by a mission to bring new medicines and treatments to patients faster./ppAs a values-driven organisation, integrity, collaboration, agility, and inclusion are at the heart of how we work and interact with each other, customers, patients and suppliers./ph3Senior Director, Drug Development Consulting Hepatology/h3pAt ICON plc, we are driven by commitment to People, Clients, and Performance. We are seeking a strategic Hepatology expert to join our Drug Development Consulting team in a highly visible, client-facing role./ppThis position offers the opportunity to act as a trusted advisor to senior stakeholders across the industry, including CEOs, CMOs, and other Hepatology Therapeutic Area Heads. You will deliver bespoke, asset-centric solutions while shaping Hepatology drug development strategies across the full lifecycle./ph3The Role/h3pThis is a consultative and advisory role where you will serve as a key scientific partner to both external clients and internal teams. Often acting as the first technical point of contact, you will play a critical role in pre-sales activities, proposal strategy, and long-term partnership development within Hepatology./ph3Key Responsibilities/h3ulliLead strategic Hepatology drug development program design, delivering tailored, asset-focused solutions across liver diseases including MASLD/MASH, alcohol-associated liver disease (ALD), cirrhosis, viral hepatitis, and other chronic and rare liver conditions like PBC, PSC, PFIC/liliOwn end-to-end protocol development, including design, scientific review, and evaluation for Hepatology clinical trials across Phases IIV/liliPartner directly with senior client stakeholders (e.g., CMO, TA Heads, Clinical Development leadership) to provide expert guidance on Hepatology development strategy and data interpretation/liliAct as scientific and strategic lead in proposal development, study strategy, and bid defense activities within Hepatology/liliBuild and maintain strong relationships with Hepatology key opinion leaders (KOLs), advisory boards, and relevant regulatory authorities/liliContribute to the development of Hepatology-focused service offerings, supporting innovation and growth in liver disease drug development capabilities/liliProvide training, mentorship, and thought leadership in Hepatology to internal teams and external partners/liliParticipate in portfolio reviews, governance discussions, and scientific oversight of Hepatology programs/liliSupport operational teams with high-level scientific input, including investigator meetings and Hepatology-specific study discussions/liliRepresent the organization at Hepatology congresses and scientific forums to promote clinical excellence and scientific leadership/li/ulh3What You Bring/h3ulliDeep, recognized expertise in Hepatology and liver disease drug development/liliStrong understanding of Hepatology clinical trial design, biomarkers, endpoints (e.g., fibrosis staging, histologic and non-invasive markers), and evolving therapeutic landscapes (e.g., MASLD/MASH, alcohol-associated liver disease (ALD), cirrhosis, immuno-Hepatology approaches and antiviral therapies)/liliProven ability to operate in a strategic, client-facing, consultative environment within pharmaceutical or clinical research settings/liliExperience engaging and influencing senior scientific and clinical stakeholders across industry and academia/liliExcellent communication and presentation skills, with the ability to translate complex Hepatology data into clear, actionable development insights/liliCollaborative, global mindset with strong cross-functional leadership capability/liliMD required, ideally with specialization or substantial clinical/research experience in Hepatology/li/ulh3Additional Information/h3ulli20- 40% travel (domestic and international)/liliOpportunity to work in a highly visible, impact-driven role shaping the future of Hepatology drug development/li/ul/div